Industry Topic

Topic

Dan leads the Vizient pharmacy program, which assists customer hospitals in transforming their pharmacy program into a central point of integrated care with solutions that help manage cost and improve quality outcomes for patients. Under his direction, the program supports more than half the nation&rsquo;s health systems and a robust portfolio of 12,000 contracted pharmaceutical products, providing access, choice and value across acute, specialty, non-acute, home infusion and long-term care facilities.
Dan has been an active voice on behalf of Vizient customers. He regularly updates government leaders and elected and federal officials, including the Food and Drug Administration, on issues and trends related to drug price increases, shortages and the need for more transparency across the pharmaceutical supply chain.
Dan also oversees Vizient&rsquo;s highly successful, 30-year Novaplus private label pharmacy program. Under his leadership, the program has expanded to include an Enhanced Supply program that helps ensure the availability of essential medications in the supply chain.
Under Dan&rsquo;s leadership, the Vizient pharmacy team has published important analysis of the hidden costs of drug shortages and pricing practices for existing drugs after receiving regulatory approval. His team also published a list of essential medicines, the absence of which could threaten hospitals&rsquo; ability to provide care.
With a doctor of pharmacy from St. Louis College of Pharmacy, Dan joined Vizient through the MedAssets integration, where he previously served as general manager of pharmacy. He has a diverse background in the pharmaceutical industry that includes experience in benefits management, retail, hospital, specialty and mail order.
Dan is a frequent industry speaker and has been interviewed and quoted in numerous publications such as NBC, CNN, Bloomberg News, Politico, Modern Healthcare, Becker&rsquo;s Hospital Review, Drug Topics, Managed Healthcare and The Center for Biosimilars. He has been recognized in the industry as a NextGeneration Pharmacist award finalist and as the 2022 Change Maker of the Year for the work he has led on ending drug shortages.

Group Senior Vice President, Pharmacy Solutions

Dan Kistner, PharmD

Shoshana Krilow, senior vice president of public policy and government relations, leads Vizient&rsquo;s Public Policy and Government Relations office, monitoring and advocating on federal legislative and regulatory developments of importance to Vizient and its members.
Prior to joining Vizient, Krilow served as director of health and clinical affairs for the University of California, focusing on issues related to health policy and biomedical research for the UC Health system. Krilow has also worked as a strategic advisor to health sector clients with a particular concentration on Medicare, the pharmaceutical and insurance industries, and the Affordable Care Act.
Krilow brings deep legislative expertise to Vizient having spent several years on Capitol Hill, where she worked as a health policy advisor for members of the House of Representatives and the Senate. Prior to her work on Capitol Hill, Krilow worked as an analyst, investment advisor, and regional, internal wholesaler for Goldman, Sachs and Co., Smith Barney, and J.P. Morgan respectively.
Krilow received her law degree from The Ohio State University in 2007 and became a member of the Ohio State Bar later that year. She is also a graduate of the University of Michigan where she received her Bachelor of Arts degrees in English and Psychology.

Senior Vice President, Public Policy and Government Relations

Shoshana Krilow

With a health care career spanning more than 25 years, Jim has extensive experience in health care advisory services with hospitals, health systems and physician practices nationwide. The nature of his health care consulting includes hospital/physician alignment, value-based care initiatives, bundled payments, strategic planning, new service development and implementation services.
Prior to joining Vizient, Jim was a founder of TRG Health Care Solutions, a hospital/physician alignment company he led for 14 years. Previous to TRG, Reilly led the health care consulting division for GE Medical Systems. He has led more than 350 projects during his consulting career with a proven track record in physician relations, project management, communications, team building and financial analysis.
Jim is a national speaker and often presents to organizations such as American College of Cardiovascular Administrators (ACCA), American College of Healthcare Executives (ACHE), American Medical Group Association (AMGA), Healthcare Financial Management Association (HFMA) and Society of Thoracic Surgeons (STS).Jim received a bachelor of science degree in finance from the University of Colorado in Boulder.

Jim Reilly

Molly leads the product team, development and execution of Vizient's data and digital product strategy for new markets, including: suppliers, distributers, service firms, non-governmental organizations, employers and payers. With internal and external partners, she advances and aligns Vizient&rsquo;s comprehensive product portfolio to industry needs and opportunities, Vizient's managed services as well as customer goals and objectives.
Most recently, Molly led a team focused on the strategic alignment of spend management services with health system and supplier strategies through all areas of non-labor expense across the entire healthcare supply chain. Her scope included programs focused specifically on sustainability, supply assurance, price assurance and insights/intelligence.
Through Vizient Member Networks, Molly was previously responsible for connecting more than 320 provider organizations, including system-level executives and clinical leaders in supply chain and Vizient's Large Integrated Delivery Network (IDN) Supply Network (LISN), representing 20-25 of the nation's largest health systems and more than 500 acute care facilities, to share leading practices and data, and develop high-value solutions.
Molly's work in strategy and operations includes leveraging analytics and sourcing strategies to deliver an average of $27 million in recognized annual value to three healthcare organizations within the supply chain network she was responsible for. She also established the network's clinical leadership council, comprised of chief medical officers and supply chain executives, enabling collaboration of 40 physician leaders in clinical variation reduction.
In the provider sector, Molly was responsible for the clinical program development of a network of clinically integrated, enterprise-wide service line advancing full-continuum trauma/injury care across 900+ locations. Molly served as a co-investigator on a mild traumatic brain injury (mTBI) clinical research study in partnership with clinical research teams and launched an original cross-continuum program evaluation strategy to demonstrate a positive impact on clinical process and outcome metrics through clinical guidelines. Her efforts inspired a North Carolina Office of Emergency Medical Services research initiative. Molly also developed trauma outreach strategies, including an mTBI feature during Super Bowl XLVII.
As a two-time grad of the University of North Carolina at Chapel Hill, Molly minored in English, received her Bachelor of Science in Business Administration, and later completed her Master of Healthcare Administration. She now serves on the Next Generation Committee of the Board of UNC's Kenan-Flagler Business School and a member of the 100 Women initiative.

Experts